2023-03-07 07:33:25 ET
Tax hikes and pricing negotiations will be among the measures President Joe Biden will propose to ensure Medicare is funded for the next two decades. The plan will be part of the White House’s 2024 budget proposal, which is set for release on Thursday in Philadelphia.
“Medicare is more than a government program. It’s the rock-solid guarantee that Americans have counted on to be there for them when they retire,” Biden wrote in a guest essay in The New York Times on Tuesday.
Biden’s proposal would increase the net investment income tax to 5% from 3.8% for all Americans earning more than $400K annually. The plan will also expand the tax, applying it to additional types of income from pass-through firms.
“This modest increase in Medicare contributions from those with the highest incomes will help keep the Medicare program strong for decades to come,” Biden wrote.
In addition to taxes, Biden proposes expanding Medicare’s ability to negotiate drug costs, which was introduced with the Inflation Reduction Act last year.
The plan is set to address a looming funding crisis for a key Medicare trust fund expected within five years, according to some forecasters.
Major pharma companies: Pfizer ( NYSE: PFE ), Merck ( NYSE: MRK ), Bristol-Myers Squibb ( NYSE: BMY ), Eli Lilly ( NYSE: LLY ), AstraZeneca ( AZN ), GSK ( GSK ), Sanofi ( SNY ) ( OTCPK:SNYNF ), Novo Nordisk ( NVS ), Sanofi ( SNY ) ( OTCPK:SNYNF ), Abbott ( ABT ), AbbVie ( ABBV ), Gilead ( GILD ), Johnson & Johnson ( JNJ ), Biogen ( BIIB ), Amgen ( AMGN ) and Moderna ( MRNA )
Selected managed care players: UnitedHealth Group ( UNH ), Humana ( HUM ), Elevance Health ( ELV ), Centene ( CNC ), CVS Health ( CVS )
Dear Readers: We recognize that politics often intersect with the financial news of the day, so we invite you to click here to join the separate political discussion.
For further details see:
Biden to announce plan to keep Medicare solvent beyond 2050